Idorsia Ltd is a biopharmaceutical company based in Switzerland that discovers and develops small-molecule medicines. Its main marketed product is a treatment for insomnia, and its research pipeline spans disorders of the central nervous system, the heart and blood vessels, and the immune system. The company serves patients and healthcare professionals through prescription medicines, working with partners to bring its compounds to markets in several countries.
Idorsia Ltd trades under the code IDIA on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #163 of 226 on the SIX Swiss Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Switzerland yet.
TrendWeak
33/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-8.2%
From 52-week high-39.2%
MomentumWeak
48/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-31.1%
6-month return9.9%
12-month, skipping last month29.8%
Stability (higher is calmer)Weak
13/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)67.4%
Worst drawdown, 1 year (smaller is calmer)-41.5%
LiquidityStrong
72/100
Trades actively.
See the numbers →
Avg daily value traded5.82M CHF
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Switzerland when fundamentals data for this market is added. All Switzerland stocks.
52-wk range 2.795 – 7.560Daily closes, split-adjusted
Signals
50-day average4.805
200-day average4.561
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)0.204
Technical summary
Daily
Strongly bearish
0 bullish · 4 neutral · 12 bearish
Weekly
Bearish
3 bullish · 1 neutral · 8 bearish
Monthly
Neutral
4 bullish · 1 neutral · 3 bearish
Moving averages (daily)
SMA 10
4.21
Bearish
EMA 10
4.23
Bearish
SMA 20
4.30
Bearish
EMA 20
4.34
Bearish
SMA 50
4.80
Bearish
EMA 50
4.72
Bearish
SMA 100
5.37
Bearish
EMA 100
4.87
Bearish
SMA 200
4.56
Bearish
EMA 200
4.58
Bearish
Oscillators (daily)
RSI (14)
41.16
Neutral
MACD (12, 26)
-0.18
Bearish
Momentum (12)
-3.41
Bearish
Stochastic %K (14)
35.75
Neutral
Williams %R (14)
-64.25
Neutral
CCI (20)
-50.73
Neutral
Pivot points (classic, last session)
S3
4.00
S2
4.06
S1
4.12
Pivot
4.19
R1
4.25
R2
4.31
R3
4.37
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CHF. Educational only, not financial advice.
